CYTK PEER ANALYSIS

Cytokinetics Inc — metric-by-metric comparison with peers and the industry median

CYTKCytokinetics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CYTKIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CYTK	CSL	TLX	MSB	Ind. Median
P/E	—	29.44	—	—	17.91
P/B	-12.90●	2.20	6.37	—	3.51
EV/EBITDA	—	10.21●	120.14	—	14.82
P/S	100.76	2.62●	3.24	31.61	10.89

Financial Health
Metric	CYTK	CSL	TLX	MSB	Ind. Median
Current Ratio	4.21●	2.57	1.43	—	5.90
Debt/Equity	-155.9%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	-0.64●	2.22	13.13	—	1.15

Profitability
Metric	CYTK	CSL	TLX	MSB	Ind. Median
Net Margin	-784.0%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	—	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-65.4%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	-694.3%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	CYTK	CSL	TLX	MSB	Ind. Median
Rev. Growth	450.6%●	4.8%	56.3%	410.4%	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	CYTK	KYMR	TECH	KRYS	HALO	BMRN	Ind. Median
P/E	—	—	101.45	50.85	27.99●	43.39	17.91
P/B	-12.90●	7.19	5.33	8.96	44.45	1.88	3.51
EV/EBITDA	—	—	43.40	52.96	18.58●	22.55	14.82
P/S	100.76	215.12	9.18	27.42	6.47	3.60●	10.89

Financial Health
Metric	CYTK	KYMR	TECH	KRYS	HALO	BMRN	Ind. Median
Current Ratio	4.21	10.81●	4.49	9.46	2.76	5.81	5.90
Debt/Equity	-155.9%●	5.2%	13.9%	0.7%	976.5%	23.2%	10.9%
NetDebt/EBITDA	-0.64	1.86	0.31	-4.06●	2.93	-1.62	1.15

Profitability
Metric	CYTK	KYMR	TECH	KRYS	HALO	BMRN	Ind. Median
Net Margin	-784.0%	-612.2%	9.0%	53.9%●	23.1%	8.3%	-125.7%
ROE	—	-27.1%	5.3%	19.9%	99.4%●	4.5%	-47.5%
ROA	-65.4%	-24.4%	4.2%	18.2%●	14.3%	3.4%	-35.8%
EBITDA Margin	-694.3%	-594.7%	21.3%	48.1%●	41.4%	14.9%	-105.8%

Growth + Dividend
Metric	CYTK	KYMR	TECH	KRYS	HALO	BMRN	Ind. Median
Rev. Growth	450.6%●	-12.6%	0.2%	25.1%	39.1%	9.9%	5.1%
NI Growth	—	—	-16.8%	81.5%●	-28.1%	-48.7%	12.1%
Div. Yield	—	—	0.5%	—	—	—	0.2%
Payout	—	—	45.5%	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CYTK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.